- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting co-stimulatory molecules in autoimmune disease
Authors
Keywords
-
Journal
NATURE REVIEWS DRUG DISCOVERY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-09-18
DOI
10.1038/s41573-020-0081-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor necrosis factor receptor family co‐stimulation increases regulatory T cell activation and function via NF‐κB
- (2020) Martina Lubrano di Ricco et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Poor prognostic factors in predicting abatacept response in a phase III randomized controlled trial in psoriatic arthritis
- (2020) Philip J. Mease et al. RHEUMATOLOGY INTERNATIONAL
- Follicular helper T cell profiles predict response to costimulation blockade in type 1 diabetes
- (2020) Natalie M. Edner et al. NATURE IMMUNOLOGY
- Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in ANCA-Associated Vasculitis: A Randomized Controlled Study
- (2019) David Jayne et al. Arthritis & Rheumatology
- Pharmacokinetics, Pharmacodynamics, Immunogenicity, Safety, and Tolerability of JNJ-61178104, a Novel Tumor Necrosis Factor-Alpha and Interleukin-17A Bispecific Antibody, in Healthy Subjects
- (2019) Derrick E. Akpalu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis
- (2019) Emma Guttman-Yassky et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Treatment of primary Sjögren’s syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity
- (2019) Thomas Dörner et al. ANNALS OF THE RHEUMATIC DISEASES
- Blockade of CD40–CD154 pathway interactions suppresses ectopic lymphoid structures and inhibits pathology in the NOD/ShiLtJ mouse model of Sjögren’s syndrome
- (2019) Grazyna Wieczorek et al. ANNALS OF THE RHEUMATIC DISEASES
- Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial
- (2019) Tsutomu Takeuchi et al. ANNALS OF THE RHEUMATIC DISEASES
- A CD40L-targeting protein reduces autoantibodies and improves disease activity in patients with autoimmunity
- (2019) Jodi L. Karnell et al. Science Translational Medicine
- Exogenous activation of tumor necrosis factor receptor 2 promotes recovery from sensory and motor disease in a model of multiple sclerosis
- (2019) Roman Fischer et al. BRAIN BEHAVIOR AND IMMUNITY
- Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease
- (2019) Robert J. Benschop et al. mAbs
- Effect of belimumab on proteinuria and anti-phospholipase A2 receptor autoantibody in primary membranous nephropathy
- (2019) Christine Barrett et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
- (2019) Kevan C. Herold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Laboratory mice born to wild mice have natural microbiota and model human immune responses
- (2019) Stephan P. Rosshart et al. SCIENCE
- Autoimmunity, checkpoint inhibitor therapy and immune-related adverse events: A review
- (2019) Shaheen Khan et al. SEMINARS IN CANCER BIOLOGY
- CTLA-4–mediated transendocytosis of costimulatory molecules primarily targets migratory dendritic cells
- (2019) Vitalijs Ovcinnikovs et al. Science Immunology
- Efficacy and safety of bleselumab in kidney transplant recipients: A phase 2, randomized, open‐label, noninferiority study
- (2019) Robert C. Harland et al. AMERICAN JOURNAL OF TRANSPLANTATION
- An Integrative Approach to Inform Optimal Administration of OX40 Agonist Antibodies in Patients with Advanced Solid Tumors
- (2019) Rui Wang et al. CLINICAL CANCER RESEARCH
- Characterization of the in vitro and in vivo properties of CFZ533, a blocking and non-depleting anti-CD40 monoclonal antibody
- (2018) Jacinda Ristov et al. AMERICAN JOURNAL OF TRANSPLANTATION
- From autoinflammation to autoimmunity: old and recent findings
- (2018) Francesco Caso et al. CLINICAL RHEUMATOLOGY
- A selective CD28 antagonist and rapamycin synergise to protect against spontaneous autoimmune diabetes in NOD mice
- (2018) Alix Besançon et al. DIABETOLOGIA
- A New Venue of TNF Targeting
- (2018) Sophie Steeland et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Combination of rituximab and abatacept as an exit strategy for repetitive B-cell depletion in children with severe autoimmune diseases: a report of three cases
- (2018) F Speth et al. LUPUS
- RANKL/RANK/OPG Axis Is Deregulated in the Cerebrospinal Fluid of Multiple Sclerosis Patients at Clinical Onset
- (2018) Anton Glasnović et al. NEUROIMMUNOMODULATION
- Randomized study of adjunctive belimumab in participants with generalized myasthenia gravis
- (2018) Karen Hewett et al. NEUROLOGY
- T follicular helper–like cells contribute to skin fibrosis
- (2018) Devon K. Taylor et al. Science Translational Medicine
- Bispecific antibodies: design, therapy, perspectives
- (2018) Sergey Sedykh et al. Drug Design Development and Therapy
- Efficacy and Safety of Atacicept in Patients With Systemic Lupus Erythematosus
- (2018) Joan T. Merrill et al. Arthritis & Rheumatology
- Brief Report: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple-Dose Study to Evaluate AMG 557 in Patients With Systemic Lupus Erythematosus and Active Lupus Arthritis
- (2018) Laurence E. Cheng et al. Arthritis & Rheumatology
- Subcutaneous Abatacept in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis
- (2018) Hermine I. Brunner et al. Arthritis & Rheumatology
- ABT-122, a Bispecific DVD-Immunoglobulin Targeting TNF- and IL-17A, in RA With Inadequate Response to Methotrexate: A Randomized, Double-Blind Study
- (2018) Mark C. Genovese et al. Arthritis & Rheumatology
- Phase 2 Study of ABT-122, a TNF- and IL-17A-Targeted Dual Variable Domain Immunoglobulin, in Psoriatic Arthritis With Inadequate Methotrexate Response
- (2018) Philip J. Mease et al. Arthritis & Rheumatology
- Clinical Efficacy and Safety of Baminercept, a Lymphotoxin β Receptor Fusion Protein, in Primary Sjögren's Syndrome
- (2018) E. William St.Clair et al. Arthritis & Rheumatology
- CD28 blockade controls T cell activation to prevent graft-versus-host disease in primates
- (2018) Benjamin K. Watkins et al. JOURNAL OF CLINICAL INVESTIGATION
- CD40 Inhibition with CFZ533 - A New, Fully Human, Non-Depleting, Fc Silent mAB - Improves Renal Allograft Function While Demonstrating Comparable Efficacy vs. Tacrolimus in De-Novo CNI-Free Kidney Transplant Recipients
- (2018) B Nashan et al. TRANSPLANTATION
- Inhibition of Membrane-Bound BAFF by the Anti-BAFF Antibody Belimumab
- (2018) Christine Kowalczyk-Quintas et al. Frontiers in Immunology
- Phase I randomized study of KHK4083, an anti-OX40 monoclonal antibody, in patients with mild to moderate plaque psoriasis
- (2017) K.A. Papp et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- OX40: Structure and function – What questions remain?
- (2017) Jane Willoughby et al. MOLECULAR IMMUNOLOGY
- Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases
- (2017) Michael Croft et al. Nature Reviews Rheumatology
- T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition
- (2017) Enfu Hui et al. SCIENCE
- Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependent
- (2017) Alice O. Kamphorst et al. SCIENCE
- Combined OX40L and mTOR blockade controls effector T cell activation while preserving T reg reconstitution after transplant
- (2017) Victor Tkachev et al. Science Translational Medicine
- Belimumab for the Treatment of Early Diffuse Systemic Sclerosis
- (2017) Jessica K. Gordon et al. Arthritis & Rheumatology
- Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled Study
- (2017) William Stohl et al. Arthritis & Rheumatology
- Targeting the Human T-Cell Inducible COStimulator Molecule with a Monoclonal Antibody Prevents Graft-vs-Host Disease and Preserves Graft vs Leukemia in a Xenograft Murine Model
- (2017) Aude Burlion et al. Frontiers in Immunology
- Delayed Cytotoxic T Lymphocyte-Associated Protein 4-Immunoglobulin Treatment Reverses Ongoing Alloantibody Responses and Rescues Allografts From Acute Rejection
- (2016) J. S. Young et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The expression of Bcl-6 in circulating follicular helper-like T cells positively correlates with the disease activity in systemic lupus erythematosus
- (2016) Xin Huang et al. CLINICAL IMMUNOLOGY
- Rationale for anti-OX40 cancer immunotherapy
- (2016) Sandrine Aspeslagh et al. EUROPEAN JOURNAL OF CANCER
- CD28 days later: Resurrecting costimulation for CD8+memory T cells
- (2016) Verena van der Heide et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion
- (2016) Martin Chopra et al. JOURNAL OF EXPERIMENTAL MEDICINE
- CD4+Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis
- (2016) Florence Roan et al. JOURNAL OF IMMUNOLOGY
- Loss of Immune Tolerance Is Controlled by ICOS in Sle1 Mice
- (2016) Nanette Mittereder et al. JOURNAL OF IMMUNOLOGY
- A CD80-Biased CTLA4-Ig Fusion Protein with Superior In Vivo Efficacy by Simultaneous Engineering of Affinity, Selectivity, Stability, and FcRn Binding
- (2016) Julie Douthwaite et al. JOURNAL OF IMMUNOLOGY
- First-in-Human Study in Healthy Subjects with FR104, a Pegylated Monoclonal Antibody Fragment Antagonist of CD28
- (2016) Nicolas Poirier et al. JOURNAL OF IMMUNOLOGY
- Efficacy and safety of tabalumab plus standard of care in Japanese patients with active systemic lupus erythematosus: Subgroup analyses of the ILLUMINATE-1 study
- (2016) Yoshiya Tanaka et al. Modern Rheumatology
- Belatacept and Long-Term Outcomes in Kidney Transplantation
- (2016) Flavio Vincenti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abatacept Inhibition of T Cell Priming in Mice by Induction of a Unique Transcriptional Profile That Reduces Their Ability to Activate Antigen-Presenting Cells
- (2016) Agapitos Patakas et al. Arthritis & Rheumatology
- Brief Report: Association of Rheumatoid Factor and Anti-Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan-European Registry Analysis
- (2016) J. E. Gottenberg et al. Arthritis & Rheumatology
- ICOS Co-Stimulation: Friend or Foe?
- (2016) Daniel J. Wikenheiser et al. Frontiers in Immunology
- A Novel, Blocking, Fc-Silent Anti-CD40 Monoclonal Antibody Prolongs Nonhuman Primate Renal Allograft Survival in the Absence of B Cell Depletion
- (2015) F. Cordoba et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Efficacy and safety of tabalumab, an anti-B-cell-activating factor monoclonal antibody, in patients with rheumatoid arthritis who had an inadequate response to methotrexate therapy: results from a phase III multicentre, randomised, double-blind study
- (2015) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Impact of baseline anti-cyclic citrullinated peptide-2 antibody concentration on efficacy outcomes following treatment with subcutaneous abatacept or adalimumab: 2-year results from the AMPLE trial
- (2015) Jeremy Sokolove et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study
- (2015) J T Merrill et al. ANNALS OF THE RHEUMATIC DISEASES
- OX40, OX40L and Autoimmunity: a Comprehensive Review
- (2015) Gwilym J. Webb et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- ICOS Coreceptor Signaling Inactivates the Transcription Factor FOXO1 to Promote Tfh Cell Differentiation
- (2015) Erica L. Stone et al. IMMUNITY
- Clonal Deletion Prunes but Does Not Eliminate Self-Specific αβ CD8+ T Lymphocytes
- (2015) Wong Yu et al. IMMUNITY
- Selective Treg reconstitution during lymphopenia normalizes DC costimulation and prevents graft-versus-host disease
- (2015) Holly A. Bolton et al. JOURNAL OF CLINICAL INVESTIGATION
- ICOS maintains the T follicular helper cell phenotype by down-regulating Krüppel-like factor 2
- (2015) Jan P. Weber et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Selective CD28 Antagonist Blunts Memory Immune Responses and Promotes Long-Term Control of Skin Inflammation in Nonhuman Primates
- (2015) Nicolas Poirier et al. JOURNAL OF IMMUNOLOGY
- ATON: Results from a Phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis
- (2015) Robert C. Sergott et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Treatment of systemic lupus erythematosus patients with the BAFF antagonist “peptibody” blisibimod (AMG 623/A-623): results from randomized, double-blind phase 1a and phase 1b trials
- (2015) William Stohl et al. ARTHRITIS RESEARCH & THERAPY
- FR104, an Antagonist Anti-CD28 Monovalent Fab' Antibody, Prevents Alloimmunization and Allows Calcineurin Inhibitor Minimization in Nonhuman Primate Renal Allograft
- (2014) N. Poirier et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Renal Transplantation Using Belatacept Without Maintenance Steroids or Calcineurin Inhibitors
- (2014) A. D. Kirk et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial)
- (2014) David Isenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- Reduction in CD4 Central Memory T-Cell Subset in Costimulation Modulator Abatacept-Treated Patients With Recent-Onset Type 1 Diabetes Is Associated With Slower C-Peptide Decline
- (2014) T. Orban et al. DIABETES
- Protective effects of Fc-fused PD-L1 on two different animal models of colitis
- (2014) Mi-Young Song et al. GUT
- Follicular helper T cell signature in type 1 diabetes
- (2014) Rupert Kenefeck et al. JOURNAL OF CLINICAL INVESTIGATION
- 2B4 (CD244) induced by selective CD28 blockade functionally regulates allograft-specific CD8+T cell responses
- (2014) Danya Liu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Down-Regulation of ICOS Ligand by Interaction with ICOS Functions as a Regulatory Mechanism for Immune Responses
- (2014) M. Watanabe et al. JOURNAL OF IMMUNOLOGY
- ICOS Ligation Recruits the p50 PI3K Regulatory Subunit to the Immunological Synapse
- (2014) C. Fos et al. JOURNAL OF IMMUNOLOGY
- FOXO1 Regulates L-Selectin and a Network of Human T Cell Homing Molecules Downstream of Phosphatidylinositol 3-Kinase
- (2014) S. Fabre et al. JOURNAL OF IMMUNOLOGY
- B7RP-1 Blockade Ameliorates Autoimmunity through Regulation of Follicular Helper T Cells
- (2014) Y.-L. Hu et al. JOURNAL OF IMMUNOLOGY
- The Immunoregulator Soluble TACI Is Released by ADAM10 and Reflects B Cell Activation in Autoimmunity
- (2014) Franziska S. Hoffmann et al. JOURNAL OF IMMUNOLOGY
- CTLA-4 Is Expressed by Activated Mouse NK Cells and Inhibits NK Cell IFN- Production in Response to Mature Dendritic Cells
- (2014) A. Stojanovic et al. JOURNAL OF IMMUNOLOGY
- Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial
- (2014) Ludwig Kappos et al. LANCET NEUROLOGY
- Advantages ofPapio anubisfor preclinical testing of immunotoxicity of candidate therapeutic antagonist antibodies targeting CD28
- (2014) Nicolas Poirier et al. mAbs
- Genetic and epigenetic fine mapping of causal autoimmune disease variants
- (2014) Kyle Kai-How Farh et al. NATURE
- Continuous requirement for the TCR in regulatory T cell function
- (2014) Andrew G Levine et al. NATURE IMMUNOLOGY
- A p85α-osteopontin axis couples the receptor ICOS to sustained Bcl-6 expression by follicular helper and regulatory T cells
- (2014) Jianmei W Leavenworth et al. NATURE IMMUNOLOGY
- Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations
- (2014) Desirée Schubert et al. NATURE MEDICINE
- CTLA-4 controls follicular helper T-cell differentiation by regulating the strength of CD28 engagement
- (2014) Chun Jing Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4
- (2014) H. S. Kuehn et al. SCIENCE
- Pharmacokinetics and Pharmacodynamics of ASKP1240, a Fully Human Anti-CD40 Antibody, in Normal and Renal Transplanted Cynomolgus Monkeys
- (2014) Anlun Ma et al. TRANSPLANTATION
- Rituximab-Induced T Cell Depletion in Patients With Rheumatoid Arthritis: Association With Clinical Response
- (2013) J. Mélet et al. ARTHRITIS AND RHEUMATISM
- CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients
- (2013) Jennifer Pieper et al. BMC IMMUNOLOGY
- OX40L blockade and allergen-induced airway responses in subjects with mild asthma
- (2013) G. M. Gauvreau et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Agonistic CD40 Antibodies and Cancer Therapy
- (2013) R. H. Vonderheide et al. CLINICAL CANCER RESEARCH
- Follicular helper T cells may play an important role in the severity of primary Sjögren's syndrome
- (2013) Krisztina Szabo et al. CLINICAL IMMUNOLOGY
- Human regulatory T cells are selectively activated by low-dose application of the CD28 superagonist TGN1412/TAB08
- (2013) Paula Tabares et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Local BLyS production by T follicular cells mediates retention of high affinity B cells during affinity maturation
- (2013) Radhika Goenka et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Efficacy and Safety of Belimumab in Patients with Rheumatoid Arthritis: A Phase II, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study
- (2013) W. Stohl et al. JOURNAL OF RHEUMATOLOGY
- Immune suppression in cynomolgus monkeys by XPro9523
- (2013) Matthew J. Bernett et al. mAbs
- Follicular T-helper cell recruitment governed by bystander B cells and ICOS-driven motility
- (2013) Heping Xu et al. NATURE
- The microRNA cluster miR-17∼92 promotes TFH cell differentiation and represses subset-inappropriate gene expression
- (2013) Dirk Baumjohann et al. NATURE IMMUNOLOGY
- Human autoimmunity after lymphocyte depletion is caused by homeostatic T-cell proliferation
- (2013) J. L. Jones et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Golimumab, a Human Anti-Tumor Necrosis Factor Monoclonal Antibody, Injected Subcutaneously Every 4 Weeks in Patients With Active Rheumatoid Arthritis Who Had Never Taken Methotrexate: 1-Year and 2-Year Clinical, Radiologic, and Physical Function Findings
- (2013) Paul Emery et al. ARTHRITIS CARE & RESEARCH
- CTLA4Ig Prevents Alloantibody Formation Following Nonhuman Primate Islet Transplantation Using the CD40-Specific Antibody 3A8
- (2012) I. R. Badell et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Preclinical Efficacy and Immunological Safety of FR104, an Antagonist Anti-CD28 Monovalent Fab′ Antibody
- (2012) N. Poirier et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Cell-intrinsic and -extrinsic control of Treg-cell homeostasis and function revealed by inducedCD28deletion
- (2012) Tea Gogishvili et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Constitutive Clathrin-mediated Endocytosis of CTLA-4 Persists during T Cell Activation
- (2012) Omar S. Qureshi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Therapeutic Potential of B and T Lymphocyte Attenuator Expressed on CD8 + T Cells for Contact Hypersensitivity
- (2012) Daiki Nakagomi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Atacicept in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a phase II, randomized, placebo-controlled trial
- (2011) R. F. van Vollenhoven et al. ARTHRITIS AND RHEUMATISM
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- TACI deficiency impairs sustained Blimp-1 expression in B cells decreasing long-lived plasma cells in the bone marrow
- (2011) S. Tsuji et al. BLOOD
- Crystallographic and Mutational Analysis of the CD40-CD154 Complex and Its Implications for Receptor Activation
- (2011) Hyun-Jung An et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sustained antibody responses depend on CD28 function in bone marrow–resident plasma cells
- (2011) Cheryl H. Rozanski et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Combination Therapy of Abatacept and Anakinra in Children with Refractory Systemic Juvenile Idiopathic Arthritis: A Retrospective Case Series
- (2011) J. L. RECORD et al. JOURNAL OF RHEUMATOLOGY
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4
- (2011) O. S. Qureshi et al. SCIENCE
- Immunosuppression with Belatacept-Based, Corticosteroid-Avoiding Regimens in De Novo Kidney Transplant Recipients
- (2010) R. Ferguson et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4+ effector memory T-cells
- (2010) D Eastwood et al. BRITISH JOURNAL OF PHARMACOLOGY
- Rigid-body Ligand Recognition Drives Cytotoxic T-lymphocyte Antigen 4 (CTLA-4) Receptor Triggering
- (2010) Chao Yu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting of B and T lymphocyte associated (BTLA) prevents graft-versus-host disease without global immunosuppression
- (2010) Jörn C. Albring et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Inducing CTLA-4-Dependent Immune Regulation by Selective CD28 Blockade Promotes Regulatory T Cells in Organ Transplantation
- (2010) N. Poirier et al. Science Translational Medicine
- An Enigmatic Tail of CD28 Signaling
- (2010) J. S. Boomer et al. Cold Spring Harbor Perspectives in Biology
- Increased ERK and JNK activities correlate with disease activity in patients with systemic lupus erythematosus
- (2009) Y Molad et al. ANNALS OF THE RHEUMATIC DISEASES
- Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus
- (2009) Nicholas Simpson et al. ARTHRITIS AND RHEUMATISM
- Defining dose–response relationships in the therapeutic blockade of B7RP-1-dependent immune responses
- (2009) Daniela P. Metz et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The significance of OX40 and OX40L to T-cell biology and immune disease
- (2009) Michael Croft et al. IMMUNOLOGICAL REVIEWS
- Abatacept Does Not Induce Direct Gene Expression Changes in Antigen-Presenting Cells
- (2009) Julie A. Carman et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Anti-CD40 Monoclonal Antibody Synergizes with CTLA4-Ig in Promoting Long-Term Graft Survival in Murine Models of Transplantation
- (2009) C. R. Gilson et al. JOURNAL OF IMMUNOLOGY
- New Insights into the Molecular Basis of T Cell Anergy: Anergy Factors, Avoidance Sensors, and Epigenetic Imprinting
- (2009) A. D. Wells JOURNAL OF IMMUNOLOGY
- Identification of BLyS (B Lymphocyte Stimulator), a Non-Myelin-Associated Protein, as a Functional Ligand for Nogo-66 Receptor
- (2009) L. Zhang et al. JOURNAL OF NEUROSCIENCE
- Inducible costimulator promotes helper T-cell differentiation through phosphoinositide 3-kinase
- (2009) M. Gigoux et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans
- (2009) K. Warnatz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The effects of PDL-Ig on collagen-induced arthritis
- (2009) Guohua Wang et al. RHEUMATOLOGY INTERNATIONAL
- Epithelial cells as immune effector cells: The role of CD40
- (2009) Kari Dugger et al. SEMINARS IN IMMUNOLOGY
- The immunobiology of CD154–CD40–TRAF interactions in atherosclerosis
- (2009) David Engel et al. SEMINARS IN IMMUNOLOGY
- The role of CD40 and CD154/CD40L in dendritic cells
- (2009) Daphne Y. Ma et al. SEMINARS IN IMMUNOLOGY
- Macrophage CD40 signaling: A pivotal regulator of disease protection and pathogenesis
- (2009) Jill Suttles et al. SEMINARS IN IMMUNOLOGY
- Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus
- (2008) Michelle Petri et al. ARTHRITIS AND RHEUMATISM
- Critical role of activation-inducible lymphocyte immunomediatory molecule/inducible costimulator in the effector function of human T cells: A comparative in vitro study of effects of its blockade and CD28 blockade in human beings and monkeys
- (2008) Nobuyuki Tajima et al. HUMAN IMMUNOLOGY
- HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase–dependent mechanism
- (2008) Olivier Manches et al. JOURNAL OF CLINICAL INVESTIGATION
- ICOS-dependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunity
- (2008) Jared M. Odegard et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells
- (2008) Aurelie T Bauquet et al. NATURE IMMUNOLOGY
- The Immunological Genome Project: networks of gene expression in immune cells
- (2008) Tracy S P Heng et al. NATURE IMMUNOLOGY
- CTLA-4 Control over Foxp3+ Regulatory T Cell Function
- (2008) K. Wing et al. SCIENCE
- Abatacept modulates human dendritic cell-stimulated T-cell proliferation and effector function independent of IDO induction
- (2007) Patricia M. Davis et al. CLINICAL IMMUNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started